Switzerland· 69816005
Ticagrelor Devatis 90 mg, Filmtabletten
A ticagrelor product containing ticagrelorum, registered in Switzerland by Devatis AG and dispensed under Swissmedic category B. The same ATC class is registered in 18 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Ticagrelor is registered in 18 of 19 countries.
Countries holding a registration under ATC B01AC24 (ticagrelor), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 10 of them publish a price we can compare per daily dose
Ticagrelor · ATC B01AC24
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of ticagrelor costs, country by country.
Normalised to the WHO defined daily dose (0.18 g), the median price runs from $0.68 in United States to $1.97 in Spain — a ×2.9 gap.
- Switzerland: $1.80 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Ticagrelor · price per daily dose (0.18 g)
USD · FX 28 Sept 2026
- ES Spain$1.97
- CH Switzerland$1.80
- IT Italy$0.94
- FR France$0.77
- US United States$0.68 (acquisition cost)
The record
At a glance
Swissmedic (Switzerland)- Active substance
- ticagrelorum
- Manufacturer
- Devatis AG
- Country
- Switzerland (CH)
- ATC code
- B01AC24
- ATC class
- Ticagrelor
- Defined daily dose
- 0.18 g, O
- Swissmedic category
- B
- Reimbursed
- No
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
529 interactions on record for ticagrelor.
Graded by severity as the source publishes them — 76 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ticagrelor · interactions on record
529 records
- 76 severe
- 354 moderate
- 60 minor
Most severe, free to view
- LonafarnibA16AX20severe
- DalteparinB01AB04severe
- EnoxaparinB01AB05severe
- DanaparoidB01AB09severe
39 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Ticagrelor in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaATIRABOTAD Pharma GmbH, Cuxhaven
- SpainBRILIQUE 90 MG COMPRIMIDOS RECUBIERTOS CON PELICULAAstrazeneca Ab
- PolandAtiraboTad Pharma GmbH
- SwedenAuretica 90 mg Filmdragerad tablettAurora Licensing S.r.l.
- NetherlandsBrilique 90 mg, filmomhulde tablettenAstraZeneca AB (Gärtunavägen)
- United StatesTicagrelorRedpharm Drug
- ItalyAURETICAAURORA LICENSING S.R.L.
- FinlandBriliqueAstraZeneca AB
Authorised across Europe · EMA
The same active substance is authorised in 31 EEA countries. Names it is sold under:
- Austria · Ticagrelor, Ticagrelor Accord
- Belgium · Ticagrelor Ab, Ticagrelor Eg
- Bulgaria · ?????????? Accord, Tilobrastil
- Cyprus · Brirem, Lacrat
- Czechia · Atirabo, Atixarso
- Germany · Ticabril, Ticagrelor
- Denmark · Lacrat, Ticagrelor Accord
- Estonia · Agtileq, Atirabo
- Spain · Lacrat, Ticagrelor Abdi
- Finland · Ticagrelor Accord, Ticagrelor Avansor
- France · Ticagrelor Accord, Ticagrelor Arrow
- United Kingdom (Northern Ireland) · Bellaflow, Clariflow
- Greece · Agilinta, Atixarso
- Croatia · Atixarso, Greccas
- Hungary · Atirabo, Atixarso
- Ireland · Ticagrelor Accord, Ticagrelor Bluefish
- Iceland · Brilique, Ticagrelor Krka
- Italy · Auretica, Ticagrelor
- Liechtenstein · Brilique
- Lithuania · Atirabo, Atixarso
- Luxembourg · Ticagelor Eg (Eurogenerics) Nv, Ticagrelor Eg
- Latvia · Atirabo, Atixarso
- Malta · Brirem, Croalcril
- Netherlands · Ticagrelor Abdi, Ticagrelor Accord
- Norway · Brilique, Ticagrelor Accord
- Poland · Atirabo, Atixarso
- Portugal · Brirem, Lacrat Mg
- Romania · Atixarso, Croalcril
- Sweden · Auretica, Ecugra
- Slovenia · Atixarso, Lacrat
- Slovakia · Atirabo, Atixarso
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ae336158-411d-4475-afc9-c10d7680a66d GET /v1/drugs/ae336158-411d-4475-afc9-c10d7680a66d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{}See everything about ticagrelor.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.